
Medpace Investor Relations Material
Latest events

Q1 2025
Medpace
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Medpace Holdings Inc
Access all reports
Medpace Holdings Inc., a full-service clinical research organization, provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers therapeutic expertise in the areas of endocrinology, gastroenterology, general medicine, hematology/oncology, infectious diseases/vaccines, and neuroscience.
Key slides for Medpace Holdings Inc


Q1 2025
Medpace Holdings Inc


Q1 2025
Medpace Holdings Inc
Latest articles
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
Ticker symbol
MEDP
Country
🇺🇸 United States